Altimmune(ALT)
$1.56-0.08 (-5.17%)
ALT
Altimmune earnings date
$1.56
At close:-0.08 (-5.17%)
Want to see ALT full AI Analyst Report?
Altimmune (ALT) Q2 2026 Earnings Report
3,808 Followers
ALT Q2 2026 EPS Results
- Actual EPS
- -$0.12
- Consensus EPS
- -$0.14
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- -$0.27
ALT Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 12, 2026
ALT Upcoming Earnings
Altimmune's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
ALT Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
ALT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.17- | -0.27 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.13-0.15 | -0.21 | 28.57% (+0.06) | |
| Aug 12, 2026 | 2026 (Q2) | -0.14-0.12 | -0.27 | 55.56% (+0.15) | |
| May 13, 2026 | 2026 (Q1) | -0.24-0.18 | -0.26 | 30.77% (+0.08) | |
| Mar 05, 2026 | 2025 (Q4) | -0.24-0.27 | -0.33 | 18.18% (+0.06) | |
| Nov 06, 2025 | 2025 (Q3) | -0.27-0.21 | -0.32 | 34.38% (+0.11) | |
| Aug 12, 2025 | 2025 (Q2) | -0.34-0.27 | -0.35 | 22.86% (+0.08) | |
| May 13, 2025 | 2025 (Q1) | -0.35-0.26 | -0.34 | 23.53% (+0.08) | |
| Feb 27, 2025 | 2024 (Q4) | -0.33-0.33 | -0.54 | 38.89% (+0.21) | |
| Nov 12, 2024 | 2024 (Q3) | -0.36-0.32 | -0.39 | 17.95% (+0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

